<SEC-DOCUMENT>0001040130-24-000004.txt : 20240208
<SEC-HEADER>0001040130-24-000004.hdr.sgml : 20240208
<ACCEPTANCE-DATETIME>20240208160356
ACCESSION NUMBER:		0001040130-24-000004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240207
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240208
DATE AS OF CHANGE:		20240208

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		24608964

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pets-20240207.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pets-20240207</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001040130</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pets-20240207.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-07</xbrli:startDate><xbrli:endDate>2024-02-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8fa13b5ef3ac451f88b44b93f6eb16fe_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">February 7, 2024</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">PetMed Express, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Florida</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-28827</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">65-0680967</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">420 South Congress Avenue</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Delray Beach</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">33445</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">561</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">526-4444</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">PETS</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" id="f-19">NASDAQ</ix:nonNumeric> Global Select Market</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><div id="i8fa13b5ef3ac451f88b44b93f6eb16fe_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February&#160;8, 2024, PetMed Express, Inc. (the &#8220;Company&#8221;) issued a press release announcing selected preliminary unaudited financial results for the fiscal quarter ended December&#160;31, 2023. These preliminary financial results are unaudited, based on currently available information and do not present all necessary information for a complete understanding of the Company&#8217;s financial condition as of December&#160;31, 2023 or its results of operations for the quarter ended December&#160;31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information furnished in this Item 2.02 on this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div id="i8fa13b5ef3ac451f88b44b93f6eb16fe_143"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.</span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 7, 2024, following discussions with the Company&#8217;s management and based on management&#8217;s recommendation, the Audit Committee of the Board of Directors of the Company (the &#8220;Audit Committee&#8221;), concluded that the Company&#8217;s previously issued audited consolidated financial statements as of March 31, 2023 and 2022 and for the years ended March 31, 2023, 2022, and 2021 included in the Company&#8217;s Annual Report on Form 10-K for the year ended March 31, 2023 (the &#8220;2023 Annual Report&#8221;), and the Company&#8217;s unaudited condensed consolidated financial statements included in the Quarterly Reports on Form 10-Q for the quarterly periods within those years (the &#8220;Historical Quarterly Reports&#8221;), as well as the unaudited condensed consolidated financial statements included in the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the &#8220;Q1 2024 Quarterly Report&#8221;) and the quarter ended September 30, 2023 (the &#8220;Q2 2024 Quarterly Report&#8221; and together with the Q1 2024 Quarterly Report, the 2023 Annual Report and the Historical Quarterly Reports, the &#8220;Reports&#8221; and all financial statements included in the Reports, collectively the &#8220;Affected Financials&#8221;), should no longer be relied upon. As a result of the foregoing determined, related press releases, shareholder communications, investor presentations or other communications describing relevant portions of the Affected Financials should no longer be relied upon.</span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee&#8217;s conclusion was based on management&#8217;s determination that the Company (1) misapplied generally accepted accounting principles relating to certain accruals for sales tax liabilities resulting from sales of the Company&#8217;s products and services to its customers and (2) incorrectly valued the deferred tax asset acquired in connection with the Company&#8217;s acquisition of PetCareRx in April 2023, in each case, impacting one or more periods described in the Reports.  </span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As previously disclosed by the Company in the 2023 Annual Report, as a result of a sales tax assessment received by the Company in the fiscal year ended March 31, 2023, the Company evaluated its sales tax positions in various jurisdictions for potential additional sales tax exposure.  Following such evaluation and after consultation with the Company&#8217;s outside consultants, the Company previously recorded an accrual for additional sales tax liabilities as at March 31, 2023 (the &#8220;Additional Sales Tax Liabilities&#8221;) based on a probable and estimable approach under Accounting Standards Codification Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  In conjunction with the preparation of the Company's Quarterly Report on Form 10-Q for the quarterly period ended December&#160;31, 2023, management of the Company reviewed its accounting for sales tax liabilities, including the Additional Sales Tax Liabilities, and determined that the Company should have accounted for sales tax liabilities using a legal liability approach under Accounting Standards Codification Topic 405, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Liabilities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in the Affected Financials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  At that time, the Company also reviewed the accounting treatment relating to its deferred tax asset acquired in connection with the acquisition of PetCareRx in April 2023 and determined that it should have applied a limitation adjustment to the net operating losses acquired.</span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The extent of the errors and any resulting adjustments is not yet known as the Company&#8217;s analysis has not been completed; however, the Company expects that the restatement relating to sales tax liabilities will require the Company to record a sales tax liability of between approximately $14 million and $20 million as of March 31, 2020 (reflecting the maximum potential sales tax liability as of such date). Because this liability gets adjusted in subsequent periods, the Company expects this maximum sales tax liability to be between approximately $16 million and $23 million as of March 31, 2023.  The most significant impact to the income statement resulting from the restatement relating to sales tax liabilities is expected to be a decrease in general and administrative expense in the range of $6 million to $8 million for the Company&#8217;s fiscal year ended March 31, 2023, resulting from a reversal of the Additional Sales Tax Liabilities accrued as of March 31, 2023, and a corresponding increase to the Company&#8217;s net income for the same period. The Company expects that the restatement relating to its valuation of the deferred tax asset recorded in connection with the PetCareRx acquisition will increase goodwill and decrease the deferred tax asset on the Company&#8217;s balance sheet as at June 30, 2023. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While the Company believes that the foregoing description fairly summarizes the expected material impact of the restatement on the Company&#8217;s Affected Financials, the Company is unable at this time to estimate the final amounts and effects of the required restatements of the Affected Financials.  The Company continues to work expeditiously to conclude its analysis and complete any required restatement of its Affected Financials as soon as practicable.  </span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee, the Board of Directors, and management of the Company have begun implementing measures to enhance processes and controls and continue to evaluate appropriate remediation actions. In addition, management continues to assess the effect of any restatements on the Company&#8217;s internal controls over financial reporting and its disclosure controls and procedures. The Company expects to report one or more material weaknesses following the completion of its analysis discussed above.</span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Company management and the Audit Committee have discussed the matters disclosed in this Item 4.02 with the Company&#8217;s independent registered public accounting firm, RSM US LLP. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i8fa13b5ef3ac451f88b44b93f6eb16fe_149"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01 Regulation FD Disclosure.</span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result of the restatement described above, the Company will experience a delay in the filing of its Quarterly Report on Form 10-Q for the quarter ended December&#160;31, 2023 (the &#8220;Q3 2024 10-Q&#8221;) and expects to file a notification of late filing on Form 12b-25 with the SEC. </span></div><div style="text-align:justify;text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information furnished in this Item 7.01 on this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div id="i8fa13b5ef3ac451f88b44b93f6eb16fe_10"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits.</span></div><div style="margin-top:10pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1 &#8211; Press release dated February&#160;8, 2024.</span></div><div style="padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104 &#8211; Cover Page Interactive Data File (formatted as Inline XBRL).</span></div><div style="padding-left:54pt"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">This Current Report on Form 8-K contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements. Words such as &#8220;may,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;outlook,&#8221; &#8220;strategy,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;seek,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;strive,&#8221; &#8220;goal,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar words and expressions are intended to signify forward-looking statements. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management, are inherently uncertain and are subject to various risks and uncertainties, including: the expected adjustments to the Company&#8217;s financial statements, including the estimated amount and impact of adjustments on the Company&#8217;s financial statements, and the potential for additional adjustments to the Company&#8217;s financial statements resulting from the restatement described above. The Company&#8217;s future results may also be impacted by other risk factors listed from time to time in the Company&#8217;s filings with the Securities and Exchange Commission (&#8220;SEC&#8221;), including, but not limited to, the Company's Annual Report on Form 10-K for the year ended March 31, 2023, as well as other subsequent filings on Form 10-Q and periodic filings on Form 8-K. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Current Report on Form 8-K and should not be relied upon as representing the Company&#8217;s views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements, other than as may be required by law. If the Company does update one or more forward-looking statements, no inference should be made that the Company will make additional updates with respect to those or other forward-looking statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3</span></div></div></div><div id="i8fa13b5ef3ac451f88b44b93f6eb16fe_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20231231xexx991special.htm">Press release dated</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> February&#160;8, 2024</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL)</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4</span></div></div></div><div id="i8fa13b5ef3ac451f88b44b93f6eb16fe_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February&#160;8, 2024</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PETMED EXPRESS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">/s/ Christine Chambers</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Christine Chambers</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Financial Officer, Treasurer and Secretary</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pets-20231231xexx991special.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iad432fd023d141d0a1b5be99c5d5c3c1_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">PetMeds&#174; Announces Selected Preliminary Third Quarter Financial Results</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Company to Restate Certain Previously Issued Financial Statements Due to Correction of Errors in Accounting for Tax-Related Entries&#59; Filing of Form 10-Q to be Delayed.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Delray Beach, Florida, February&#160;8, 2024 &#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> PetMed Express, Inc. (NASDAQ&#58; PETS) (&#8220;PetMeds&#8221; or the &#8220;Company&#8221;), Your Trusted Pet Health Expert</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, today announced its selected preliminary financial results for its third quarter ended December&#160;31, 2023. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">These preliminary financial results are unaudited, based on currently available information and do not present all necessary information for a complete understanding of the Company&#8217;s financial condition as of December&#160;31, 2023 or its results of operations for the quarter ended December&#160;31, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Quarterly Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Net sales for the quarter ended December&#160;31, 2023, are expected to be $65.3&#160;million, compared to $58.9&#160;million for the third quarter in the prior year, an increase of 11.0% year over year. The current quarter includes the results from the recent acquisition of PetCareRx. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Gross profit in the quarter ended December&#160;31, 2023, is expected to be $17.9&#160;million, compared to $15.2&#160;million in the prior year period. Gross margin improved to 27.4% in the quarter ended December&#160;31, 2023 from 25.9% in the prior year period.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Cash and equivalents at December&#160;31, 2023 are expected to be $49.4&#160;million.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8220;Having to restate previously issued financial statements is certainly disappointing, but the restatement is a matter of tax accounting and will have no impact on our current cash balance,&#8221; said Matt Hulett, CEO and President. &#8220;From an operational perspective, we are encouraged to see the continued growth of recurring revenue as driven by our AutoShip &#38; Save and PetPlus programs, which represented 52.2% of revenue during the quarter, up from 42.3% for the same quarter last year.&#8221; Hulett continued, &#8220;PetMeds is on a mission to deepen our engagement with our over two million pet parents, offering them an expanded portfolio of products and services on a regular, recurring basis. The introduction of a premium food brand and a substantial enhancement to our AutoShip &#38; Save program mark pivotal steps in our transformation.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Restatement of Certain Historical Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As reported in the Company's Form 8-K filed today, at the recommendation of the Company&#8217;s management, the Audit Committee of the Board of Directors of the Company (the &#8220;Audit Committee&#8221;), has concluded that the Company&#8217;s previously issued audited consolidated financial statements as of March 31, 2023 and 2022 and for the years ended March 31, 2023, 2022, and 2021 included in the Company&#8217;s Annual Report on Form 10-K for the year ended March 31, 2023 (the &#8220;2023 Annual Report&#8221;), and the Company&#8217;s unaudited condensed consolidated financial statements included in the Quarterly Reports on Form 10-Q for the quarterly periods within those years (the &#8220;Historical Quarterly Reports&#8221;), as well as the unaudited condensed consolidated financial statements included in the Company&#8217;s Quarterly Report on Form 10-Q for the three months ended June 30, 2023 (the &#8220;Q1 2024 Quarterly Report&#8221;) and the three months ended September 30, 2023 (the &#8220;Q2 2024 Quarterly Report&#8221; and together with the Q1 2024 Quarterly Report, the 2023 Annual Report and the Historical Quarterly Reports, the &#8220;Reports&#8221; and all financial statements included in the Reports, collectively the &#8220;Affected Financials&#8221;), should no longer be relied upon. As a result of the foregoing, related press releases, shareholder communications, investor presentations or other communications describing relevant portions of the Affected Financials should no longer be relied upon.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In preparing our 2023 Annual Report, we determined that an accrual for sales tax contingencies was required.  As such, we recorded a sales tax accrual in the second and fourth quarters of fiscal year 2023 based on a determination that the sales tax liability was probable and estimable, and that such treatment was in accordance with what we believed to be the appropriate guidance from generally accepted accounting principles (GAAP). In the third quarter of fiscal year 2024, the Company reviewed, in conjunction with its auditors, RSM US LLP, the accounting treatment related to its previously reported sales tax accruals as well as the accounting treatment related to the deferred tax asset associated with the Company&#8217;s acquisition of PetCareRx in April 2023. As a result of this review, the Audit Committee concluded, based on management&#8217;s determination, that the Company incorrectly applied GAAP as it relates to the sales tax liability included in the periods contained in the Affected Financials, and that it improperly valued the deferred tax asset and goodwill reported in the first and second quarter of fiscal year 2024. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Expected Impact&#59; Increase in Net Income for FY 2023, and Increase in Recorded Tax Liability Starting in FY 2020</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company expects the impact of the restatement to affect multiple periods. The most significant impact to the income statement is expected to be a decrease to general and administrative expense for fiscal year 2023 in the range of $6 million to $8 million and a corresponding increase in net income for the same period. This amount was originally recorded as a </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.1 Page 1 of  3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">sales tax liability based on a probable and estimable approach, in fiscal year 2023, rather than the correct, legal liability approach, under which the sales tax liability would have been recorded for periods included in the Affected Financials. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The restatement is expected to require the Company to revise and record a sales tax liability of approximately $14 to $20 million as of March 31, 2020 (reflecting the maximum potential sales tax liability as of such date). Because this liability gets adjusted in subsequent periods, as of March 31, 2023, we expect to record a maximum potential sales tax liability of approximately $16 to $23 million, and the liability is adjusted as amounts are settled or released in subsequent periods. While the Company believes that the foregoing description fairly represents the expected impact of the restatement on the Company&#8217;s prior financial statements as it relates to the sales-tax accrual, further adjustments may arise, and the Affected Financials as restated will reflect any such additional adjustments.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, the Company has determined that the accounting related to the valuation of the carried forward net operating loss resulted in an overstated deferred tax asset reported at June 30 and September 30, 2023 related to the PetCareRx acquisition and will also be revised. This will increase goodwill and decrease the deferred tax asset on the balance sheet at such dates. This revision is a result of a technical tax matter surrounding the limitation adjustment to the net operating losses acquired. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">No Expected Impact on Fiscal Year 2024 Revenue, Cost of Goods Sold, or Cash</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The restatement is not expected to have an impact on the Company&#8217;s fiscal year 2024 revenue or cost of goods sold and does not impact cash. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8220;As soon as these technical accounting issues were identified, the PetMeds internal team immediately took action, in conjunction with our auditors, RSM, to identify the potential impact on past financial statements,&#8221; said Christine Chambers, Chief Financial Officer of PetMeds. &#8220;The restatement, while unfortunate, is not expected to impact our day to day business operations or strategic priorities. As we look ahead, we remain confident in our strategy and ability to drive long-term value.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Next Steps</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As a result of the level of administrative effort and time associated with completing the restatement, the Company will experience a delay in the filing of its Quarterly Report on Form 10-Q for the quarter ended December&#160;31, 2023 (the Q3 Fiscal Year 2024 10-Q) and expects to file a notification of late filing on Form 12b-25 with the SEC on or before February 9, 2024. </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Conference Call</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">This afternoon the Company will host a conference call to review selected preliminary third quarter financial results. </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Time&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4&#58;30 P.M. Eastern Time, February&#160;8, 2024</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Public call dial in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> (877) 407-0791 (toll free) or (201) 689-8563.&#160; </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Webcast stream link</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">https&#58;&#47;&#47;investors.petmeds.com&#47;overview&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;for those who wish to stream the call via webcast.&#160; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Replay&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Available until November 13, 2023, at 11&#58;59 P.M Eastern Time. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To access the replay, call (844) 512-2921 (toll free) or (412) 317-6671 and enter passcode 13741999.</font></div><div style="margin-top:10pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">About PetMeds </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Founded in 1996, PetMeds is Your Trusted Pet Health Expert&#8482;,  providing prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline">www.petmeds.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">.</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release may contain &#8220;forward-looking&#8221; statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company&#8217;s ability to meet the objectives included in its business plan.&#160; Important factors that could cause results to differ materially from those indicated by such &#8220;forward-looking&#8221; statements are set forth in the &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; section  in the Company&#8217;s Annual Report on Form 10-K for the year ended March&#160;31, 2023.&#160; The Company&#8217;s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Qs and its Annual Reports on Form 10-K.&#160;</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.1 Page 2 of  3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMEDS INVESTOR RELATIONS CONTACT</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brian M. Prenoveau, CFA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MZ Group</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">561-489-5315</font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investor&#64;petmeds.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PETMEDS MEDIA CONTACT</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mary Eva Tredway</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Butin PR</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">maryeva&#64;butinpr.com</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit 99.1 Page 3 of  3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>pets-20240207.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7b6a73f5-59bc-42fb-bed7-fc4be59447e1,g:f5e55523-12fb-400e-bd50-9f6a5a2a7fe2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pets="http://www.1800petmeds.com/20240207" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20240207">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20240207_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20240207_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.1800petmeds.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>pets-20240207_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7b6a73f5-59bc-42fb-bed7-fc4be59447e1,g:f5e55523-12fb-400e-bd50-9f6a5a2a7fe2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_e95f0491-b114-4bcd-9c8d-d20585a20446_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1fd78725-8fa5-4233-8075-b5a1d227b7f2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_b589c3ca-4e0a-4b28-837b-fb873e7e85ab_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c9a1c1cb-e435-4d0c-9b07-330523611dc4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_39b94116-7551-483c-804c-344cde195184_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f99918f2-6172-428a-bb33-3d551dd1972d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2f1d224e-704f-4831-a695-71b36933fbc4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ba193b4c-9f17-43ce-8fe0-29495b6308b7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b22e4c88-a62f-47e5-91a1-e70af045682e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_17f180c2-6e05-44ef-956d-de6d34f2517f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8b5bce81-4e85-4b16-93c9-07f039290e80_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_4a1cea77-dcdd-482b-b38c-c7914be4e8a7_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6137fa39-38f6-4304-b05f-0abd6fe954b8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_650eb987-87dd-4aa0-b4c9-3bd52ed1b08e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f48d75e0-93a2-47d2-8aab-d09a9173b609_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0cddfdfd-07a7-42a0-9ca1-c234806a6a2c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_abdfbe40-6aa1-4e04-890e-eb3762e38066_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_55484b28-4988-4585-a2ce-be497090fc93_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_10956c13-5f4c-403c-a26b-cf1fe4bc193c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_26194d69-a076-459b-9f88-4aabf6edc7a8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_819c3ff0-8dda-4592-971f-bdb4328c3512_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9f395816-57f8-4146-9d99-c8ca23f63179_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>pets-20240207_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7b6a73f5-59bc-42fb-bed7-fc4be59447e1,g:f5e55523-12fb-400e-bd50-9f6a5a2a7fe2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20240207.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3a0f9815-66bd-4725-ae44-211305241ecd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_DocumentType_3a0f9815-66bd-4725-ae44-211305241ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_39d8bea2-943b-499b-8d91-22e300599957" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_DocumentPeriodEndDate_39d8bea2-943b-499b-8d91-22e300599957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_99bf7ac9-98ae-4597-b526-adcd55765f02" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityRegistrantName_99bf7ac9-98ae-4597-b526-adcd55765f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_64551301-7b32-4211-a3d2-9e85f8adabdf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_64551301-7b32-4211-a3d2-9e85f8adabdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5aaf19f9-a660-4675-9fe7-0758600846ee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityFileNumber_5aaf19f9-a660-4675-9fe7-0758600846ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_5e7b17d4-487f-424f-8187-0d807917279b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityTaxIdentificationNumber_5e7b17d4-487f-424f-8187-0d807917279b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_50a42431-b203-4a54-aaad-26ce3a62f121" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityAddressAddressLine1_50a42431-b203-4a54-aaad-26ce3a62f121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_65192a12-e9c6-4c79-96e5-ef41b8feaf62" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityAddressCityOrTown_65192a12-e9c6-4c79-96e5-ef41b8feaf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b515ac89-fee3-45fa-aa9d-e164ea6522d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityAddressStateOrProvince_b515ac89-fee3-45fa-aa9d-e164ea6522d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3156bbac-4cad-42af-b896-fe7a0e74835d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityAddressPostalZipCode_3156bbac-4cad-42af-b896-fe7a0e74835d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fab70acd-9e80-4787-886a-361048b90124" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_CityAreaCode_fab70acd-9e80-4787-886a-361048b90124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5cabfe25-a329-4ca8-9760-ec6970b9e569" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_LocalPhoneNumber_5cabfe25-a329-4ca8-9760-ec6970b9e569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_129e5eb9-2819-412e-aaa2-a22dd2c341e7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_WrittenCommunications_129e5eb9-2819-412e-aaa2-a22dd2c341e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_023e4a1a-204c-4740-bbdd-d6f953abb7bb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_SolicitingMaterial_023e4a1a-204c-4740-bbdd-d6f953abb7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_d5454ae2-3823-4af4-ac68-6681c3fe79f5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_PreCommencementTenderOffer_d5454ae2-3823-4af4-ac68-6681c3fe79f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_c3a09f20-2a1c-4955-a704-32dcce22aac4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_c3a09f20-2a1c-4955-a704-32dcce22aac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_93e34ff4-bd5f-48de-864f-9e02dfa58e29" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_Security12bTitle_93e34ff4-bd5f-48de-864f-9e02dfa58e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b0f70187-cb2c-4dd3-b11f-47c2ac2d41b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_TradingSymbol_b0f70187-cb2c-4dd3-b11f-47c2ac2d41b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_83c645fa-38e5-4143-a95d-d460b01b2d31" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_SecurityExchangeName_83c645fa-38e5-4143-a95d-d460b01b2d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4335cae4-9a6a-4879-b54a-fd5e0bfeb8f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityEmergingGrowthCompany_4335cae4-9a6a-4879-b54a-fd5e0bfeb8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8b12b377-8169-4100-bfe0-966dad88587b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_EntityCentralIndexKey_8b12b377-8169-4100-bfe0-966dad88587b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_efb49070-a7c9-4bae-b523-5148af8021bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_631a2e7c-cda7-443c-8d65-c886f848c6e2" xlink:to="loc_dei_AmendmentFlag_efb49070-a7c9-4bae-b523-5148af8021bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140473145574016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 07, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  07,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PetMed Express, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( 'N 2%@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " ![@$A80PTM>.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9)1
M2\,P$,>_BN2]O315D=#E9<,G!<&!XEM(;EM8DX;DI-VWMZU;A^@'\#%W__SN
M=W"-B=)T"5]2%S&1PWPS^#9D:>**'8BB!,CF@%[G<DR$L;GKDM<T/M,>HC9'
MO4<0G-^#1])6DX8)6,2%R%1CC30)-77IC+=FP<?/U,XP:P!;]!@H0U56P-0T
M,9Z&MH$K8((1)I^_"V@7XES]$SMW@)V30W9+JN_[LJ_GW+A#!>_/3Z_SNH4+
MF70P./[*3M(IXHI=)K_5Z\WVD2G!Q6W!1<$?MJ*2O)9W]<?D^L/O*NP[ZW;N
M'QM?!%4#O^Y"?0%02P,$%     @ >X!(6)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M@,^72IF/ACV[EC\]#/\#4$L#!!0    ( 'N 2%B?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M 5!+ 0(4 Q0    ( 'N 2%@'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ >X!(6$,-+7CO    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ >X!(6)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " ![@$A8TF^7=T8$  "&$   &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ >X!(6)^@&_"Q @  X@P   T              ( !B@P  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " ![@$A8EXJ[',     3 @  "P
M@ %F#P  7W)E;',O+G)E;'-02P$"% ,4    " ![@$A8JL0B%C,!   B @
M#P              @ %/$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M>X!(6"0>FZ*M    ^ $  !H              ( !KQ$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ >X!(6&60>9(9 0  SP,  !,
M             ( !E!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  WA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pets-20240207.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="pets-20240207.htm">pets-20240207.htm</File>
    <File>pets-20240207.xsd</File>
    <File>pets-20240207_lab.xml</File>
    <File>pets-20240207_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "pets-20240207.htm": {
   "nsprefix": "pets",
   "nsuri": "http://www.1800petmeds.com/20240207",
   "dts": {
    "inline": {
     "local": [
      "pets-20240207.htm"
     ]
    },
    "schema": {
     "local": [
      "pets-20240207.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20240207_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20240207_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.1800petmeds.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20240207.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20240207.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001040130-24-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001040130-24-000004-xbrl.zip
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M\AAJ0B,L2-RVG5V*4GY$.R#E?BM\GFMAD\-J(!3_X">#/VSS%@@>X6<X*G+
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M>_@$=0(U&L\[[.C]Y/$3?OH_^&L.>?KX*1WO>-W1WGYW//3&WX3:V>POI+9
M;7Y\OC,Z;,ECG_#UVO56#'].)D_'<$_QNN)XP:%"% 'XXL=/\=O<X,\JGC]^
M2B% K<2"DPE,D>HTN]8$_LXEV/"F7.)G^WNT/]/OX/X_4$L#!!0    ( 'N
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ML9&,J9R3XRI!Y^,;EP\#AL=<(764TXG!EY8XJK*U-W[%;KC"H"FZ@"<)S5K
MTRSZQ#Q@U! <+E4E@\"M;TRW7>'0O?Z,@H ATH91$V0)542%S$5/UR,\(#Q2
M!$02^%3N;\H.E:_MSIV>UD_:)]MZ<RVG?M(\6>O-;?Y]NW&TU1O?'%"MYB9^
M[RHG-W%CF^$,'=F\PO#9>&F+S>Y6=M*H;:M)0$$(&5J5-(Q +_=$#*'^O">\
MHM+&/ Y&AQ$+I;C#>3)MW09M#?AQCZY7-@>1]] >I*'$ZU8M;-4'[C,8/ *
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M%S#"Y\"<V#X<!S2&C2AH?6GW#ZV%J9Q1H,?(7['N)27&N)PSEV&-F(&[Y6C
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MN!L$,8"Q8$"<!E8MYU8K7:Q -?U%8;:,< A-V>*90X<N# O41G1:1.E7X[(
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M7G/?N,)HIP%X?4IL!-Y#WQV+JQ 4JA0#7>#^%7-IQ!4H&=CH9*5WH<?;+#/
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M;>)=9]S(_<_35ZM7DL57:9^^^C]02P,$%     @ >X!(6'N<5N6L!@  Y#
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M<W!E8VEA;"YH=&U02P$"% ,4    " ![@$A826U)EFL:  #QI   $0
M        @ 'P$@  <&5T<RTR,#(T,#(P-RYH=&U02P$"% ,4    " ![@$A8
MD4NN66P"  !Y!P  $0              @ &*+0  <&5T<RTR,#(T,#(P-RYX
M<V102P$"% ,4    " ![@$A8*\V.!T4*   :70  %0              @ $E
M,   <&5T<RTR,#(T,#(P-U]L86(N>&UL4$L! A0#%     @ >X!(6'N<5N6L
M!@  Y#   !4              ( !G3H  '!E=',M,C R-# R,#=?<')E+GAM
7;%!+!08     !0 % %$!  !\00     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>pets-20240207_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pets-20240207.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2024-02-07</startDate>
            <endDate>2024-02-07</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001040130</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-02-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">PetMed Express, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-28827</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">526-4444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
